5th NeuroNetworking Event (2-25-14): Successes in NeuroVenture Financing

5th NeuroNetworking Event,  Successes in NeuroVenture Financing

Successes in NeuroVenture Financing

Time: Tuesday February 25, 6:00-8:30 pm

Generously Hosted by: STRATOS, 2401 Elliott Avenue, Seattle WA 98121

Wine, beer, other refreshments and food will be served.

Please consider donating $20 at the Door to partially defray costs.

Invited Panel:

Greg Demopulos – CEO, Omeros

John Bowers – COO, Kona Medical

Tom Clement – CEO, Aqueduct Neurosciences

Mike Hite – CEO, Impel Neuropharma

Leen Kawas – CEO, M3 Biotechnology

Steve Runnels – CEO, Proteotech

Rick Johnson – Co-Founder, Technical Illusions

Rich Wohns, Medical Director – Pacific Rim Minimally Invasive Outpatient Spine Surgery Center

These regional luminaries will describe financing their neuro companies through public placement, venture capital, angels, grants, patient advocacy organizations, and crowdfunding. We expect a dynamic interactive discussion with the audience about what’s working, what’s generalizable, and what changes are coming for our entrepreneurial NeuroNeighborhood.

Be sure to mark this event on your calendar, and we’ll see you there!

About NWNN

The NorthWest NeuroNeighborhood (www.NWNN.org) is a Washington State non-profit organization formed in the summer of 2012, dedicated to fostering the development of the emerging neuro-related cluster in the Pacific Northwest.   Follow us on Twitter @NWNeuroNeighbor.

We thank our sponsors for their enthusiastic support: Stratos,  K&L Gates, The NSF Engineering Research Center for Sensorimotor Neural Engineering at the University of Washington, Swedish Neuroscience InstituteThe Allen Institute for Brain Science, Washington Biotechnology & Biomedical Association: WBBA, UW Medicine Department of Radiology, and Omeros.

Posted by Lance Stewart, Ph.D. MBA, Sr. Director of Alliances at the Allen Institute for Brain Science and Northwest NeuroNeighborhood Co-Founder and Board Member.

7 comments to 5th NeuroNetworking Event (2-25-14): Successes in NeuroVenture Financing